Lifecore Biomedical, Inc.
LFCR
$7.24
-$0.52-6.70%
NASDAQ
| 05/25/2025 | 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.27M | 5.42M | 9.46M | 5.52M | 8.46M |
| Total Receivables | 43.67M | 41.65M | 30.30M | 25.15M | 31.15M |
| Inventory | 32.29M | 34.60M | 39.21M | 41.64M | 39.98M |
| Prepaid Expenses | 1.45M | 2.55M | 2.89M | 1.88M | 1.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 85.68M | 84.21M | 81.86M | 74.18M | 81.03M |
|
|
|||||
| Total Current Assets | 85.68M | 84.21M | 81.86M | 74.18M | 81.03M |
| Net Property, Plant & Equipment | 123.48M | 126.01M | 152.88M | 151.13M | 126.36M |
| Long-term Investments | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M |
| Goodwill | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M |
| Total Other Intangibles | 4.20M | 4.20M | 4.20M | 4.20M | 4.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.10M | 9.40M | 2.57M | 3.43M | 28.48M |
| Total Assets | 239.34M | 237.69M | 255.39M | 246.82M | 253.96M |
|
|
|||||
| Total Accounts Payable | 8.22M | 7.41M | 14.97M | 18.01M | 16.33M |
| Total Accrued Expenses | 8.06M | 9.74M | 11.48M | 13.36M | 9.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.82M | 4.90M | 4.89M | 4.91M | 4.91M |
| Total Finance Division Other Current Liabilities | 10.08M | 9.07M | 3.95M | 4.24M | 7.96M |
| Total Other Current Liabilities | 10.08M | 9.07M | 3.95M | 4.24M | 7.96M |
| Total Current Liabilities | 30.18M | 31.12M | 35.29M | 40.52M | 38.87M |
|
|
|||||
| Total Current Liabilities | 30.18M | 31.12M | 35.29M | 40.52M | 38.87M |
| Long-Term Debt | 127.00M | 118.16M | 119.03M | 127.15M | 123.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 7.28M | 7.42M | 4.80M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.73M | 33.71M | 33.89M | 34.85M | 37.46M |
| Total Liabilities | 191.91M | 190.27M | 195.63M | 207.32M | 200.06M |
|
|
|||||
| Common Stock & APIC | 206.58M | 206.32M | 206.91M | 178.82M | 177.84M |
| Retained Earnings | -205.24M | -204.09M | -191.46M | -182.75M | -166.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.34M | 2.23M | 15.45M | -3.94M | 11.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 46.10M | 45.20M | 44.31M | 43.44M | 42.59M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 46.10M | 45.20M | 44.31M | 43.44M | 42.59M |
|
|
|||||
| Total Common Equity | 1.34M | 2.23M | 15.45M | -3.94M | 11.32M |
| Total Preferred Equity | 46.10M | 45.20M | 44.31M | 43.44M | 42.59M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 47.43M | 47.43M | 59.76M | 39.50M | 53.90M |
|
|
|||||